Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy

(NASDAQ:ELTX), Received supportive FDA feedback on key elements of the potential ELI-002 Phase 3 study design, including dose, schedule, patient population and primary endpoint analysis Phase 2 randomized study of ELI-002 fully enrolled, with formal interim analysis of disease-free survival (“DFS”) expected in H1 2025; positive results could support rapid advancement into Phase 3 development […]

Streamline Health(R) Announces Fourth CommunityWorks RevID Contract With Kentucky-Based Health System

(NASDAQ:STRM), ATLANTA, Jan. 22, 2025 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of RevID with a 120-bed, Oracle Health-EHR based health system with facilities in Kentucky. Closed in partnership

United Community Banks, Inc. Reports Fourth Quarter and Full Year Results

(NYSE:UCB),(NYSE:UCB-PI), GREENVILLE, S.C., Jan. 22, 2025 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (United) today announced net income for the fourth quarter of 2024 of $75.8 million and pre-tax, pre-provision income of $108 million. Diluted earnings per share of $0.61 for the quarter represented an increase of $0.50 from the fourth quarter a

Intellia Therapeutics Announces First Patient Dosed in the HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema

(NasdaqGM:NTLA), CAMBRIDGE, Mass., Jan. 22, 2025 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced the first patient has been dosed in the global Phase 3 study of NTLA-2002 for the treatment of hereditary angioedema (HAE). NTLA-2002 is a wholly owned investigational

Coherent Introduces Pin-Hole Array Biochips for Medical Diagnostics

(NYSE:COHR), PITTSBURGH, Jan. 22, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR), a global leader in laser and photonic solutions, today announces the launch of new pin-hole array biochips for medical diagnostics, with a focus on gene sequencing applications. Developed by the Coherent advanced optics team, this groundbreaking approach consolidates the entire production process, addressing

New Study Reveals HydroGraph’s Fractal Graphene(TM) Enhances Cement Performance

(CNSX:HG.CN),(OTC US:HGRAF),(Other OTC:HGRAF),(Frankfurt:M98), TORONTO, Jan. 22, 2025 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (FRA: M98) (the “Company” or “HydroGraph”), a sustainable commercial manufacturer of pristine graphene, has announced its second research study in partnership with Arizona State University (ASU) highlighting the advancements in extending the use of HydroGraph's Fractal Graphene(TM)

Rekor Scout(R) Certified for New Jersey’s $13M Public Safety Initiative, Empowering Law Enforcement with Advanced Technology

(NASDAQ:REKR), COLUMBIA, Md., Jan. 22, 2025 (GLOBE NEWSWIRE) — Rekor Systems, Inc. (NASDAQ: REKR), a leader in developing and implementing state-of-the-art roadway intelligence technology, has achieved New Jersey's rigorous certification for its industry-leading Rekor Scout(R) vehicle recognition platform. This milestone secures Rekor's strong position in the New Jersey Statewide Networked ALPR Program (NJ SNAP), a

Stock Yards Bancorp Reports Record Fourth Quarter Earnings of $31.7 Million or $1.07 Per Diluted Share and Record Earnings for the Year

(NASDAQ:SYBT), LOUISVILLE, Ky., Jan. 22, 2025 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in Louisville, central, eastern and northern Kentucky, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today reported record earnings of $31.7 million, or $1.07 per diluted

Ally and CardWorks Reach Agreement on Sale of Ally’s Credit Card Business

Sale enables Ally to be more focused on its core businesses;acquisition enhances CardWorks' position as a leading credit card issuer and servicer Ally Financial Inc. (NYSE:ALLY) and CardWorks, Inc. today announced that they have entered into a definitive agreement for CardWorks, and its wholly-owned bank subsidiary, Merrick Bank, to acquire Ally's credit card business, including

Did Newmont Corporation Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate – NEM

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Newmont Corporation ("Newmont Corporation") (NYSE:NEM) concerning possible violations of federal securities laws. On October 23, 2024, Newmont reported 3Q 2024 earnings that fell below expectations, as well as rising operational costs. Management

Scroll to Top